Related Experiment Video
Updated: Jun 10, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Primary aldosteronism with right-dominant heart failure
Kazuro Sugishita1, Hironori Muraoka, Akiko Kawana
1Department of Cardiology, JR Tokyo General Hospital, Shibuya-ku, Tokyo, Japan.
International Heart Journal
|August 19, 2010
Summary
This study highlights hyperaldosteronism-induced cardiomyopathy as a cause of severe heart failure. Early diagnosis and treatment with aldosterone receptor blockers are crucial for managing this condition.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Severe heart failure in an obese hypertensive male with atrial flutter.
- Unexplained hypokalemia and cardiac dysfunction.
- Diagnostic challenges in identifying the etiology of primary aldosteronism.
Observation:
- Patient presented with severe right-dominant heart failure, hypokalemia, and cardiac hypertrophy.
- Despite extensive workup, the cause of primary aldosteronism remained unclear.
- Aggressive management with aldosterone receptor blockers and diuretics stabilized heart failure symptoms.
Findings:
- Primary aldosteronism was diagnosed and treated, leading to potassium normalization and heart failure control.
- Coronary arteries were normal, and endomyocardial biopsy showed no specific pathology.
- Hyperaldosteronism-induced cardiomyopathy was suspected as the cause of heart failure, distinct from hypertensive heart disease.
Implications:
- Suggests hyperaldosteronism-induced cardiomyopathy as a potential cause of heart failure.
- Emphasizes the importance of considering endocrine disorders in unexplained heart failure.
- Highlights the role of aldosterone receptor blockers in managing such cases.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...